Literature DB >> 23182138

Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain.

José M Ramos1, Diego Torrús, Concepción Amador, Francisco Jover, Fabiola Pérez-Chacón, Yamileth Ponce, Francisco J Arjona, Elena Caro, Concepción Martínez-Peinado, Ingrid Gallegos, José M Cuadrado, Antonio Tello, Felix Gutiérrez.   

Abstract

Recently, there has been an increase in the number of patients with Chagas disease outside of areas that are generally considered endemic. The aim of this investigation is to describe the clinical profile of a series of patients with Chagas disease in Alicante, Spain, which is a province located on the coast of the Mediterranean Sea. This study was performed at four general hospitals in Alicante between January 2002 and May 2011. A total of 128 patients from seven countries were diagnosed with Trypanosoma cruzi. The main country of origin of these patients was Bolivia (n5101; 78.9%), and the median of age of these patients was 35 years (range: 0–72 years). Four (3.3%) patients were children under 14 years of age, and 81 (63.3%) were female. Polymerase chain reaction (PCR) was used to analyze 106 patients, 66.0% of whom demonstrated positive PCR results. Visceral involvement was diagnosed in 26.8%: 24.1% demonstrated cardiac involvement, 0.9% demonstrated gastrointestinal involvement, 0.9% demonstrated cardiac and gastrointestinal involvement, and 0.9% demonstrated involvement of the central nervous system. Syncope was found to be associated with cardiomyopathy (28.0% versus 5.2%) (odds ratio: 6.5; 95% confidence interval: 1.5–27.1). Seventy-six patients received treatment with benznidazole, of whom 57 (75.0%) completed the treatment course without significant adverse events and 17.1% discontinued benznidazole due to adverse events. In total, 50% of patients experienced documented adverse reactions. Among patients with positive PCR results before treatment, all demonstrated negative PCR results following treatment. In conclusion, majority of our patients were female Bolivians immigrants, one of four of our patients demonstrated cardiac involvement, and treatment tolerance was poor. It is important to improve the clinical and epidemiological knowledge of Chagas disease in nonendemic with additional multicenter studies in order to determine the magnitude of this problem and provide improved public health and health resource planning.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182138      PMCID: PMC4005132          DOI: 10.1179/2047773212Y.0000000039

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  24 in total

Review 1.  [Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic].

Authors:  Joaquim Gascón; Pedro Albajar; Elías Cañas; María Flores; Jordi Gómez i Prat; Ramón N Herrera; Carlos A Lafuente; Héctor L Luciardi; Alvaro Moncayo; Lluís Molina; José Muñoz; Sabino Puente; Ginés Sanz; Begoña Treviño; Xavier Sergio-Salles
Journal:  Rev Esp Cardiol       Date:  2007-03       Impact factor: 4.753

2.  Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

Authors:  Jose Antonio Marin-Neto; Anis Rassi; Carlos A Morillo; Alvaro Avezum; Stuart J Connolly; Sergio Sosa-Estani; Fernando Rosas; Salim Yusuf
Journal:  Am Heart J       Date:  2008-07       Impact factor: 4.749

3.  Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

Authors:  Yara M Gomes; Virginia M B Lorena; Alejandro O Luquetti
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

4.  Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.

Authors:  Rodolfo Viotti; Carlos Vigliano; Bruno Lococo; Graciela Bertocchi; Marcos Petti; María Gabriela Alvarez; Miriam Postan; Alejandro Armenti
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

5.  Chagas disease: a Latin American health problem becoming a world health problem.

Authors:  Gabriel A Schmunis; Zaida E Yadon
Journal:  Acta Trop       Date:  2009-11-20       Impact factor: 3.112

6.  Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain).

Authors:  Jose Muñoz; Jordi Gómez i Prat; Montserrat Gállego; Fausto Gimeno; Begoña Treviño; Pablo López-Chejade; Oriol Ribera; Lluis Molina; Sergi Sanz; María Jesús Pinazo; Cristina Riera; Elizabeth J Posada; Ginés Sanz; Montserrat Portús; Joaquim Gascon
Journal:  Acta Trop       Date:  2009-03-05       Impact factor: 3.112

Review 7.  Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina.

Authors:  Sergio Sosa-Estani; Rodolfo Viotti; Elsa Leonor Segura
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

Review 8.  Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis.

Authors:  José A Pérez-Molina; Ana Pérez-Ayala; Santiago Moreno; M Carmen Fernández-González; Javier Zamora; Rogelio López-Velez
Journal:  J Antimicrob Chemother       Date:  2009-10-09       Impact factor: 5.790

Review 9.  Gastrointestinal manifestations of Chagas' disease.

Authors:  R B de Oliveira; L E Troncon; R O Dantas; U G Menghelli
Journal:  Am J Gastroenterol       Date:  1998-06       Impact factor: 10.864

10.  Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage.

Authors:  Ana Garcia-Alvarez; Marta Sitges; María-Jesús Pinazo; Ander Regueiro-Cueva; Elizabeth Posada; Silvia Poyatos; José Tomás Ortiz-Pérez; Magda Heras; Manel Azqueta; Joaquim Gascon; Ginés Sanz
Journal:  PLoS Negl Trop Dis       Date:  2010-09-21
View more
  7 in total

1.  Healthcare Professionals and Students' Awareness of Chagas Disease: Design and Validation of Chagas Level of Knowledge Scale (ChaLKS).

Authors:  José M Ramos-Rincón; José J Mira-Solves; Violeta Ramos-Sesma; Diego Torrús-Tendero; Jara Llenas-García; Miriam Navarro
Journal:  Am J Trop Med Hyg       Date:  2020-04-23       Impact factor: 2.345

2.  Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).

Authors:  Maite Vallejo; Pedro Pa Reyes; Mireya Martinez Garcia; Alejandro G Gonzalez Garay
Journal:  Cochrane Database Syst Rev       Date:  2020-12-11

3.  Profile of Trypanosoma cruzi infection in a tropical medicine reference center, Northern Italy.

Authors:  Federico Gobbi; Andrea Angheben; Mariella Anselmi; Chiara Postiglione; Ernestina Repetto; Dora Buonfrate; Stefania Marocco; Stefano Tais; Andrea Chiampan; Paride Mainardi; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

4.  Chagas disease: a report of 17 suspected cases in Japan, 2012-2017.

Authors:  Kazuo Imai; Kazuhisa Misawa; Morichika Osa; Norihito Tarumoto; Jun Sakai; Kei Mikita; Yusuke Sayama; Yuji Fujikura; Akihiko Kawana; Takashi Murakami; Shigefumi Maesaki; Sachio Miura; Takuya Maeda
Journal:  Trop Med Health       Date:  2019-06-13

5.  Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology.

Authors:  María Velasco; Luis Andrés Gimeno-Feliú; Israel Molina; Joaquín Salas-Coronas; Ivan Solà; Begoña Monge-Maillo; Diego Torrús-Tendero; Joan Caylà; Ena Niño de Guzmán; Jl Pérez Arellano; Jose A Pérez-Molina
Journal:  Euro Surveill       Date:  2020-02

6.  Association Between Trypanosoma cruzi DNA in Peripheral Blood and Chronic Chagasic Cardiomyopathy: A Systematic Review.

Authors:  Pau Bosch-Nicolau; Juan Espinosa-Pereiro; Fernando Salvador; Adrián Sánchez-Montalvá; Israel Molina
Journal:  Front Cardiovasc Med       Date:  2022-01-31

7.  Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients.

Authors:  Fernando Salvador; Elena Sulleiro; Adrián Sánchez-Montalvá; Mónica Martínez-Gallo; Eugenia Carrillo; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2016-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.